Evidence map

ReviewMolecular cancer2026

Metabolic reprogramming in cancer: signaling pathways and therapeutic targets.

Shi Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41634663